Multiple molecules involved in AD pathogenesis [such as ApoE (Yang et al., 2011), PS1 (Gadadhar et al., 2011), and APP (Ghosal et al., 2010)] were recognized to take part in neurogenesis modulation. This evidence concerns the gene APP and Alzheimer disease.